Citius Pharmaceuticals Announces $5 Million Registered Direct Offering to Support Lymphir Launch On April 24, 2026, Citius Pharmaceuticals Inc. (Nasdaq: CTXR) announced a registered direct offering expected to generate approximately …
Tag: